Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Interleukin 12B gene polymorphism and apparent resistance to hepatitis C virus infection.

Hegazy D, Thurairajah P, Metzner M, Houldsworth A, Shaw S, Kaminski E, Demaine AG, Cramp ME.

Clin Exp Immunol. 2008 Jun;152(3):538-41. doi: 10.1111/j.1365-2249.2008.03655.x. Epub 2008 Apr 16.

2.

A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.

Knapp S, Warshow U, Ho KM, Hegazy D, Little AM, Fowell A, Alexander G, Thursz M, Cramp M, Khakoo SI.

Gastroenterology. 2011 Jul;141(1):320-5, 325.e1-2. doi: 10.1053/j.gastro.2011.04.005. Epub 2011 Apr 14.

3.

Interleukin-12B gene polymorphism frequencies in Egyptians and sex-related susceptibility to hepatitis C infection.

Youssef SS, Abd El Aal AM, Nasr AS, el Zanaty T, Seif SM.

J Interferon Cytokine Res. 2013 Aug;33(8):415-9. doi: 10.1089/jir.2012.0161. Epub 2013 Apr 19.

PMID:
23600862
4.

Relationships between interleukin-12B and interleukin-10 gene polymorphisms and hepatitis C in Chinese Han hemodialysis patients.

Zhu B, Wang C, Zhang X, He J, Wu J, Yu R, Zhao W.

Ren Fail. 2015 Apr;37(3):505-10. doi: 10.3109/0886022X.2015.1006086. Epub 2015 Jan 23.

PMID:
25613737
5.

Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection.

Warshow UM, Riva A, Hegazy D, Thurairajah PH, Kaminski ER, Chokshi S, Cramp ME.

J Viral Hepat. 2012 Jul;19(7):501-8. doi: 10.1111/j.1365-2893.2011.01574.x. Epub 2012 Jan 4.

PMID:
22676363
6.

Haplotype analysis finds linkage disequilibrium in the IL-12 gene in patients with HCV.

Houldsworth A, Metzner M, Hodgkinson A, Shaw S, Kaminski E, Demaine AG, Cramp ME.

J Med Virol. 2015 Jul;87(7):1207-17. doi: 10.1002/jmv.24179. Epub 2015 Apr 23.

PMID:
25908236
7.

Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection.

Thurairajah PH, Hegazy D, Chokshi S, Shaw S, Demaine A, Kaminski ER, Naoumov NV, Cramp ME.

J Infect Dis. 2008 Dec 15;198(12):1749-55. doi: 10.1086/593337.

PMID:
18959498
8.

Polymorphisms in the IL-12B gene and outcome of HCV infection.

Houldsworth A, Metzner M, Rossol S, Shaw S, Kaminski E, Demaine AG, Cramp ME.

J Interferon Cytokine Res. 2005 May;25(5):271-6.

PMID:
15871664
9.

Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population.

Cui Q, Zhang YX, Su J, Chen X, Ding K, Lei N, Liu Y, Li J, Zhang Y, Yu RB.

Infect Genet Evol. 2011 Oct;11(7):1682-9. doi: 10.1016/j.meegid.2011.06.016. Epub 2011 Jun 30.

PMID:
21742059
10.

IL-8 -251T/A and IL-12B 1188A/C polymorphisms are associated with gout in a Chinese male population.

Liu S, Yin C, Chu N, Han L, Li C.

Scand J Rheumatol. 2013;42(2):150-8. doi: 10.3109/03009742.2012.726372.

PMID:
23441821
11.

IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection.

Mangia A, Santoro R, Piattelli M, Pazienza V, Grifa G, Iacobellis A, Andriulli A.

Cytokine. 2004 Feb 7;25(3):103-9.

PMID:
14698136
12.
13.

Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection.

Mueller T, Mas-Marques A, Sarrazin C, Wiese M, Halangk J, Witt H, Ahlenstiel G, Spengler U, Goebel U, Wiedenmann B, Schreier E, Berg T.

J Hepatol. 2004 Oct;41(4):652-8.

PMID:
15464247
14.

Association of IL-12B genetic polymorphism with the susceptibility and disease severity of ankylosing spondylitis.

Wong RH, Wei JC, Huang CH, Lee HS, Chiou SY, Lin SH, Cai YW, Hung PH, Wang MF, Yang SF.

J Rheumatol. 2012 Jan;39(1):135-40. doi: 10.3899/jrheum.110613. Epub 2011 Nov 1.

PMID:
22045842
15.

Cytokine and apoptosis gene polymorphisms influence the outcome of hepatitis C virus infection.

Ksiaa Cheikhrouhou L, Sfar I, Aounallah-Skhiri H, Aouadi H, Jendoubi-Ayed S, Ben Abdallah T, Ayed K, Lakhoua-Gorgi Y.

Hepatobiliary Pancreat Dis Int. 2011 Jun;10(3):280-8.

PMID:
21669572
16.

Exploration of genetically determined resistance against hepatitis C infection in high-risk injecting drug users.

Sugden PB, Cameron B, Luciani F, Lloyd AR; HITS Investigators.

J Viral Hepat. 2014 Aug;21(8):e65-73. doi: 10.1111/jvh.12232. Epub 2014 Feb 26.

PMID:
24612442
17.

Interleukin-12B gene polymorphism does not confer susceptibility to Graves' ophthalmopathy in Japanese population.

Hiromatsu Y, Fukutani T, Ichimura M, Mukai T, Kaku H, Miyake I, Yamada K.

Endocr J. 2006 Dec;53(6):753-9. Epub 2006 Sep 12.

18.

Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan.

Afzal MS, Tahir S, Salman A, Baig TA, Shafi T, Zaidi NU, Qadri I.

J Infect Dev Ctries. 2011 Jul 4;5(6):473-9.

19.
20.

Relationships between tumour necrosis factor-α, interleukin-12B and interleukin-10 gene polymorphisms and hepatitis B in Chinese Han haemodialysis patients.

Wang C, Zhang X, Zhu B, Hu D, Wu J, Yu R, Zhao W.

Nephrology (Carlton). 2012 Feb;17(2):167-74. doi: 10.1111/j.1440-1797.2011.01539.x.

PMID:
22070668

Supplemental Content

Support Center